Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

3 Oct 2013 07:00

RNS Number : 6009P
Byotrol PLC
03 October 2013
 



3 October 2013

 

Byotrol plc

Acquisition of Byotrol Consumer Products Ltd

 

Byotrol plc ('Byotrol' or the 'Company'), the developer of anti-microbial hygiene technologies, is pleased to announce that on 2 October 2013 it has entered into an agreement to acquire all of the issued shares that it does not currently own in its consumer products joint venture, Byotrol Consumer Products Ltd (the "Acquisition"). The consideration for the acquisition will be the issue of 33,740,000 new ordinary shares in Byotrol plc ("Consideration Shares"). Completion is expected to take place on 9 October 2013.

 

The combination of Byotrol Consumer Product's marketing strategy and Byotrol's product and technical knowhow will create a more efficient and focussed entity enabling optimised relationships with partners who increasingly work in both consumer and business to business markets. Harnessing these specialist skills under one roof presents clear revenue growth potential through additional cross-selling opportunities, whilst synergies from the acquisition will achieve savings for the wholly-owned business.

 

Byotrol Consumer Products Ltd ("BCP") was established in 2007 as a 50:50 joint venture between Byotrol plc and ?What If! Innovation Capital Nominees Ltd. BCP was responsible for developing commercial relationships and product sales in the global consumer market.

 

Since establishment, BCP has developed valuable relationships with major organisations in the consumer products market, across a wide geography. This strategy has promoted Byotrol as a technical partner to major multinationals, whilst giving Byotrol access to global markets.

 

For the year ended 31 March 2013 the unaudited statutory accounts of Byotrol Consumer Products Ltd showed revenues of £858k and a profit before tax of £134k. The consolidation of the operations of BCP is expected to be immediately earnings enhancing for Byotrol.

 

Commenting on the acquisition, Ralph Kugler, Chairman of Byotrol, said

 

"The acquisition of BCP is an important strategic step for Byotrol in being able to fully develop market opportunities. The combination of the two companies will increase our sales opportunities in consumer and business markets at a lower overall cost. Byotrol is committed to building on BCP's achievements to maximise value for our shareholders."

 

Gary Millar, Chief Executive of Byotrol, added:

 

"The full ownership of BCP gives Byotrol the opportunity to streamline its sales focus whilst benefitting from the additional margin contribution resulting from a consumer product sales approach.

 

"We continue to see considerable opportunity for the Byotrol technology in consumer products markets and believe that better outcomes will be achieved with BCP more tightly integrated into the Company. Optimising the combined skill sets of both businesses will lead to significant market opportunities." 

 

David Traynor, Managing director of BCP, added:

 

"Having worked closely with Byotrol PLC for over 5 years, we can see that the combination of the two businesses is based on sound strategic logic and playing on our combined strengths will enhance the total organisation."

 

 

The Acquisition

 

The sellers of BCP shares are the current shareholders of BCP other than Byotrol, namely ?What IF! Holdings Ltd 2004 EBT, Bricon-Byotrol Ltd, ?What If! Holdings Ltd, Matt Kingdon, David Allan, Salil Pajwani, David Traynor, Trevor Francis and Nicholas Stanley (the "Sellers").

 

As well as the issue of Consideration Shares, the Sellers have agreed to waive all intra-group indebtedness owed by BCP to any Seller or any connected party.

 

Each of the Sellers has agreed not to dispose of any Consideration Shares for a period of 24 months from Admission (as defined below), subject to certain exceptions.

 

In addition, ?What If! Holdings Ltd has been granted a right to nominate one director to the board of Byotrol for the duration of the restriction on disposals referred to above.

 

Following completion and the issue of the Consideration Shares, Bricon-Byotrol Ltd will hold 14,599,038 Ordinary Shares in Byotrol, representing 7.96% of its enlarged issued share capital following the Acquisition.

 

 

Admission

 

The Consideration Shares will be issued from existing authorities granted to the Directors at the latest annual general meeting. The Consideration Shares represent 18.4% of the enlarged issued share capital of the Company following their issue.

 

Application has been made for the Consideration Shares to be admitted to trading on AIM ('Admission') and it is expected that such admission and dealings in the Consideration Shares will occur on AIM on 9 October 2013. The Consideration Shares will rank pari passu with the existing Ordinary Shares currently in issue. Following Admission, there will be 183,368,101 Ordinary Shares in issue.

 

 

Enquiries:

 

Byotrol plc

01925 742000

Ralph Kugler, Chairman

Gary Millar, Chief Executive

Duncan Grosvenor, Finance Director

finnCap Limited

020 7220 0500

Nominated Adviser and broker

Geoff Nash/Christopher Raggett

Simon Starr (Corporate Broking)

Winningtons

020 3176 4722

Tom Cooper / Paul Vann

0797 122 1972

tom.cooper@winningtons.co.uk

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds and algae.

 

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQNKBDBKBDBDKK
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.